CMS Open Payments · Program Year 2024
Moon Surgical
Moon Surgical reported $46,803.07 across General Payments, Research, and Ownership to 31 physicians and teaching hospitals across 31 transactions.
- $46.8K Below-median payer
- All-tracks total
- 31 Below-median volume
- Transactions
- 31 Below-median reach
- Recipients
- #1367
- of 1,925 companies
Moon Surgical reported $46,803.07 across all CMS Open Payments tracks (General + Research + Ownership) to 31 physicians and teaching hospitals in Program Year 2024 - ranking #1367 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $46,803.07, averaging $1.5K per recipient.
Moon Surgical's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer moon-surgical Moon Surgical
$46.8K · #1367/1,925 · 0.0% industry · PY2024
- TOT $46.8K
- RANK #1367
- SHARE 0.0%
- TXN 31
- RCP 31
- CAT 2
- GEN $46.8K
- TOP1 47.8%
- PY 2024
Volume peers
Nearest volume peer: EMD Millipore Corporation ($47.0K)
Moon Surgical sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Moon Surgical
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Moon Surgical that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
22 transactions worth $46.2K make "Consulting Fee" the top general-payment category in the 2-category breakdown below, 98.7% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Moon Surgical's 2-category general-payment breakdown at $46.2K, 98.7% of the reported total.
How Moon Surgical divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $46.2K | 22 | 98.7% |
| Food and Beverage | $592.32 | 9 | 1.3% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $38,757.81 (82.8%) of $46,803.07 in this company's General Payments records across 22 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Moon Surgical
The five named recipients with the highest reported General Payments from this company
- 1
Deborah Keller
$22,385.75 across 3 reported transactions
- 2
Steven Hodgett
$12,073.53 across 4 reported transactions
- 3
Craig Morgenthal
$2,023.53 across 2 reported transactions
- 4
Eric Kubat
$1,225.00 across 1 reported transactions
- 5
Michelle Li
$1,050.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Moon Surgical ranks #1367 of 1,925 by total payments (bottom 29% by spend) but is notably more concentrated than that alone would suggest -- #566 of 1,838 by HHI (top 31% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Medicaroid, Inc. : $3.1K total payments, HHI 3056
- Bard Access Systems, Inc. : $278.7K total payments, HHI 3052
- Den-Mat Holdings, LLC : $35.9K total payments, HHI 3047
- Maxx Health Inc : $11.5K total payments, HHI 3036
- Reapplix Inc. : $101.7K total payments, HHI 3032
- McKesson Specialty Care Distribution, LLC : $271.93 total payments, HHI 3010
- Moon Surgical (this company) : $46.8K total payments, HHI 3007
- Elekta AB (publ) : $740.86 total payments, HHI 3002
- Ingeniumspine, LLC : $13.0K total payments, HHI 2996
- Lenoss Medical Inc : $18.6K total payments, HHI 2991
- Biogennix, LLC : $352.9K total payments, HHI 2990
- L&K Spine Inc : $111.3K total payments, HHI 2966
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Moon Surgical's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Moon Surgical.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Moon Surgical.
Showing 6 of 1,924 companies with CMS-reported payment data.
Aspen Surgical Products, Inc.
The Walman Optical Company
Microtransponder, Inc.
HF Acquisition Co. LLC
Meisinger USA, LLC
Put this to use
Moon Surgical ranks #1367 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Moon Surgical. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.